Daclatasvir

Buy high quality Daclatasvir Impurities from Chemicea Pharma. Chemicea Pharma is one of the leading manufacturer and exporter of Daclatasvir impurities. We synthesize Daclatasvir Degradation Impurities, Daclatasvir Process Impurities, Daclatasvir Potential Impurities, Daclatasvir USP Related Compound, Daclatasvir N-Nitroso impurities, Daclatasvir nitrosamine impurities etc.

Pharmaceutical Reference Standards

Daclatasvir

CAT. No.	CP-D71000
CAS. No.	1009119-64-5
Mol. F.	C40H50N8O6
Mol. Wt.	738.89
Stock Status:	Custom Synthesis

Rel. Cas No: 1009119-65-6 (2HCl salt)

N-Nitroso Daclatasvir

CAT. No.	CP-D71001
CAS. No.	NA
Mol. F.	C40H49N9O7
Mol. Wt.	767.89
Stock Status:	Please Enquire

N-Nitroso Daclatasvir Impurity 1

CAT. No.	CP-D71002
CAS. No.	NA
Mol. F.	C40H48N10O8
Mol. Wt.	796.89
Stock Status:	Please Enquire

N-Nitroso Daclatasvir Impurity 2

CAT. No.	CP-D71003
CAS. No.	NA
Mol. F.	C40H49N9O7
Mol. Wt.	767.89
Stock Status:	Please Enquire

Daclatasvir RRRR Isomer

CAT. No.	CP-D71005
CAS. No.	NA
Mol. F.	C40H50N8O6 : 2HCl
Mol. Wt.	738.89 : 2(36.5)
Stock Status:	Custom Synthesis

Rel. Cas No: 1417333-58-4 (free base)

L-Valine Methyl Chloroformate Chain

CAT. No.	CP-D71006
CAS. No.	NA
Mol. F.	C7H14N2O3
Mol. Wt.	174.2
Stock Status:	Custom Synthesis

Daclatasvir Dihydrochloride

CAT. No.	CP-D71007
CAS. No.	1009119-65-6
Mol. F.	C40H50N8O6 : 2(HCl)
Mol. Wt.	738.9 : 2(36.46)
Stock Status:	Custom Synthesis

Rel. Cas No: 1009119-64-5 (Free base)

Daclatasvir RSSR Isomer

CAT. No.	CP-D71008
CAS. No.	1009107-27-0
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir SRRS Isomer

CAT. No.	CP-D71009
CAS. No.	1009117-26-3
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir SS Isomer

CAT. No.	CP-D71010
CAS. No.	1228552-27-9
Mol. F.	C20H25BrN4O3
Mol. Wt.	449.3
Stock Status:	Custom Synthesis

Daclatasvir RSSS Isomer

CAT. No.	CP-D71011
CAS. No.	1417333-83-5
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir RRSR Isomer

CAT. No.	CP-D71012
CAS. No.	1417333-65-3
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir RSRR Isomer

CAT. No.	CP-D71013
CAS. No.	1417333-60-8
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir SSRR Isomer

CAT. No.	CP-D71014
CAS. No.	1009117-94-5
Mol. F.	C40H50N8O6
Mol. Wt.	738.9
Stock Status:	Custom Synthesis

Daclatasvir impurity A

CAT. No.	CP-D71015
CAS. No.	1007884-60-7
Mol. F.	C33H39N7O3
Mol. Wt.	581.7
Stock Status:	Custom Synthesis

Rel. Cas No: 1258311-20-4 (HCl salt)

Daclatasvir impurity C

CAT. No.	CP-D71016
CAS. No.	1256385-55-3
Mol. F.	C29H32N6O3
Mol. Wt.	512.6
Stock Status:	Custom Synthesis

4,4`-bis-chloroacetyl-biphenyl

CAT. No.	CP-D71017
CAS. No.	24860-53-5
Mol. F.	C16H12Cl2O2
Mol. Wt.	307.2
Stock Status:	Custom Synthesis

N-(tert-Butoxycarbonyl)-L-proline

CAT. No.	CP-D71018
CAS. No.	15761-39-4
Mol. F.	C10H17NO4
Mol. Wt.	215.2
Stock Status:	Custom Synthesis

Rel. Cas No: 139240-36-1 (Na salt) ; 62007-79-8 (K salt)

Daclatasvir Impurity 3

CAT. No.	CP-D71019
CAS. No.	1009119-82-7
Mol. F.	C36H44N2O10
Mol. Wt.	664.8
Stock Status:	Custom Synthesis

Daclatasvir Impurity 4

CAT. No.	CP-D71020
CAS. No.	1007882-23-6
Mol. F.	C36H44N6O4
Mol. Wt.	624.8
Stock Status:	Custom Synthesis

Daclatasvir Impurity 5

CAT. No.	CP-D71021
CAS. No.	1009119-83-8
Mol. F.	C26H28N6 : 4HCl
Mol. Wt.	424.6 : 4(36.46)
Stock Status:	Custom Synthesis

Rel. Cas No: 1007882-27-0 (Free base)

N-(Methoxycarbonyl)-L-valine

CAT. No.	CP-D71022
CAS. No.	74761-42-5
Mol. F.	C7H13NO4
Mol. Wt.	175.2
Stock Status:	Custom Synthesis

Daclatasvir Impurity 7

CAT. No.	CP-D71023
CAS. No.	4072-67-7
Mol. F.	C16H12Br2O2
Mol. Wt.	396.1
Stock Status:	Custom Synthesis

Daclatasvir Impurity 9

CAT. No.	CP-D71024
CAS. No.	1447744-93-5
Mol. F.	C30H32N6O2
Mol. Wt.	508.6
Stock Status:	Custom Synthesis

Daclatasvir Impurity F

CAT. No.	CP-D71025
CAS. No.	2077207-88-4
Mol. F.	C41H52N8O6
Mol. Wt.	752.9
Stock Status:	Custom Synthesis

4,4`-Diacetylbiphenyl

CAT. No.	CP-D71026
CAS. No.	787-69-9
Mol. F.	C16H14O2
Mol. Wt.	238.3
Stock Status:	Custom Synthesis

2-Bromo-4`-phenylacetophenone

CAT. No.	CP-D71027
CAS. No.	135-73-9
Mol. F.	C14H11BrO
Mol. Wt.	275.1
Stock Status:	Custom Synthesis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Daclatasvir

Pharmaceutical Reference Standards

Daclatasvir

N-Nitroso Daclatasvir

N-Nitroso Daclatasvir Impurity 1

N-Nitroso Daclatasvir Impurity 2

Daclatasvir RRRR Isomer

L-Valine Methyl Chloroformate Chain

Daclatasvir Dihydrochloride

Daclatasvir RSSR Isomer

Daclatasvir SRRS Isomer

Daclatasvir SS Isomer

Daclatasvir RSSS Isomer

Daclatasvir RRSR Isomer

Daclatasvir RSRR Isomer

Daclatasvir SSRR Isomer

Daclatasvir impurity A

Daclatasvir impurity C

4,4`-bis-chloroacetyl-biphenyl

N-(tert-Butoxycarbonyl)-L-proline

Daclatasvir Impurity 3

Daclatasvir Impurity 4

Daclatasvir Impurity 5

N-(Methoxycarbonyl)-L-valine

Daclatasvir Impurity 7

Daclatasvir Impurity 9

Daclatasvir Impurity F

4,4`-Diacetylbiphenyl

2-Bromo-4`-phenylacetophenone

Domestic

International